Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Coronary heart disease and menopause management: the swinging pendulum of HRT.

Stevenson JC, Hodis HN, Pickar JH, Lobo RA.

Atherosclerosis. 2009 Dec;207(2):336-40. doi: 10.1016/j.atherosclerosis.2009.05.033. Epub 2009 Jun 6. Review.

PMID:
19560146
2.
3.

Recent epidemiological evidence relevant to the clinical management of the menopause.

Shapiro S.

Climacteric. 2007 Oct;10 Suppl 2:2-15. Review.

PMID:
17882666
4.

Menopause and stroke and the effects of hormonal therapy.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:27-31. Review.

PMID:
17882669
6.

The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.

Gurney EP, Nachtigall MJ, Nachtigall LE, Naftolin F.

J Steroid Biochem Mol Biol. 2014 Jul;142:4-11. doi: 10.1016/j.jsbmb.2013.10.009. Epub 2013 Oct 27. Review.

PMID:
24172877
7.

Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.

Banks E, Canfell K.

Am J Epidemiol. 2009 Jul 1;170(1):24-8. doi: 10.1093/aje/kwp113. Epub 2009 May 25.

PMID:
19468078
8.
9.

Hormones, menopause, and heart disease: making sense of the Women's Health Initiative.

Derry PS.

Womens Health Issues. 2004 Nov-Dec;14(6):212-9. Review.

PMID:
15589771
10.

Pitfalls of the WHIs: Women's Health Initiative.

Mastorakos G, Sakkas EG, Xydakis AM, Creatsas G.

Ann N Y Acad Sci. 2006 Dec;1092:331-40. Review.

PMID:
17308158
11.

Postmenopausal hormones and coronary artery disease: potential benefits and risks.

Lobo RA.

Climacteric. 2007 Oct;10 Suppl 2:21-6. Review.

PMID:
17882668
12.

Hormone replacement therapy and cardiovascular disease revisited.

Stevenson JC.

Menopause Int. 2009 Jun;15(2):55-7. doi: 10.1258/mi.2009.009018.

PMID:
19465669
13.

Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.

Grodstein F, Manson JE, Stampfer MJ.

J Womens Health (Larchmt). 2006 Jan-Feb;15(1):35-44.

PMID:
16417416
14.

A comparative review of the risks and benefits of hormone replacement therapy regimens.

Warren MP.

Am J Obstet Gynecol. 2004 Apr;190(4):1141-67. Review.

PMID:
15118656
15.

Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study.

Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Langer RD, Pettinger M, Hendrix SL, Hubbell FA, Kooperberg C, Kuller LH, Lane DS, McTiernan A, O'Sullivan MJ, Rossouw JE, Anderson GL.

Am J Epidemiol. 2008 Jun 15;167(12):1407-15. doi: 10.1093/aje/kwn090. Epub 2008 Apr 29.

16.

[Primary and secondary prevention of cardiovascular events through hormone replacement therapy (HRT)].

Pilz H.

Wien Med Wochenschr. 2005 Sep;155(17-18):397-403. German.

PMID:
16392437
17.

Evidence-based assessment of the impact of the WHI on women's health.

Burger HG, MacLennan AH, Huang KE, Castelo-Branco C.

Climacteric. 2012 Jun;15(3):281-7. doi: 10.3109/13697137.2012.655564. Review.

PMID:
22612616
18.
19.

On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.

Langer RD.

Climacteric. 2010 Aug;13(4):303-6. doi: 10.3109/13697137.2010.496316.

PMID:
20540591
20.

HRT and cardiovascular disease.

Stevenson JC.

Best Pract Res Clin Obstet Gynaecol. 2009 Feb;23(1):109-20. doi: 10.1016/j.bpobgyn.2008.10.010. Epub 2008 Dec 17.

PMID:
19095500

Supplemental Content

Support Center